Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723): Difference between revisions

From MaRDI portal
Set OpenAlex properties.
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: Willingness to pay for mortality risk reductions: does latency matter? / rank
 
Normal rank
Property / cites work
 
Property / cites work: Effects of disease type and latency on the value of mortality risk / rank
 
Normal rank
Property / cites work
 
Property / cites work: Age, health and the willingness to pay for mortality risk reductions: A contingent valuation survey of Ontario residents / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Reference Lottery Metric for Valuing Health / rank
 
Normal rank
Property / cites work
 
Property / cites work: A choice experiment approach to the valuation of mortality / rank
 
Normal rank
Property / cites work
 
Property / cites work: The value of a statistical life: A critical review of market estimates throughout the world / rank
 
Normal rank

Latest revision as of 11:46, 28 June 2024

scientific article
Language Label Description Also known as
English
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks
scientific article

    Statements